Nov. 11, 2002 — Hepatitis B surface antigen (HBsAg)-positive renal transplant patients have improved survival if they are preemptively treated with lamivudine, according to the results of a ...

According to study findings published in PLoS One, researchers found that cancer patients positive for hepatitis B surface antigen who underwent chemotherapy without adequate antiviral prophylaxis ...

Hepatitis B virus (HBV) can be a cause of fatal liver failure after chemotherapy for viral carrier patients and limits the indication of myeloablative therapy for them. We describe an HBsAg-positive ...

Finally, because the patient is a chronic carrier of HBV, the alpha-fetoprotein level should also be monitored every 6 months and an ultrasound examination of the liver performed annually to screen ...

To investigate the frequencies of dendritic cells (DCs) and Toll-like receptor 3 (TLR3) in neonates of HBsAg-positive mothers with different HBV serological profiles, we conducted a study in Taiyuan, ...

Pregnant women who are identified as hepatitis B surface antigen (HBsAg)-positive at antenatal screening are assessed by a specialist within 6 weeks of receiving the screening test result. Evidence of ...

Please provide your email address to receive an email when new articles are posted on . Chronic hepatitis B virus infection was significantly associated with an increased risk for intracerebral ...

Babies born to hepatitis B surface antigen (HBsAg)-positive mothers receive a complete course of hepatitis B vaccination and, at age 12 months, receive a blood test for hepatitis B infection.